1. University of Kragujevac Digital Archive
  2. University of Kragujevac
  3. Faculty of Medical Sciences, Kragujevac
Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/8785
Full metadata record
DC FieldValueLanguage
dc.rights.licenseopenAccess-
dc.contributor.authorNinic S.-
dc.contributor.authorKalaba M.-
dc.contributor.authorJovicic B.-
dc.contributor.authorVukomanovic V.-
dc.contributor.authorPrijić S.-
dc.contributor.authorVucetic, Branka-
dc.contributor.authorKravljanac R.-
dc.contributor.authorVujić, Ana-
dc.contributor.authorKosutic J.-
dc.date.accessioned2020-09-19T16:40:47Z-
dc.date.available2020-09-19T16:40:47Z-
dc.date.issued2017-
dc.identifier.issn1082-720X-
dc.identifier.urihttps://scidar.kg.ac.rs/handle/123456789/8785-
dc.description.abstract© 2017 Wiley Periodicals, Inc. Cardiac rhabdomyomas are common in tuberous sclerosis. We report a child who developed rhabdomyoma related arrhythmia refractory to antiarrhythmic drug therapy. Reversion of the atrial ectopic tachycardia was achieved with mammalian target of rapamycin pathway (mTOR) inhibitor sirolimus. As per our knowledge, this is the first time that sirolimus has been successfully used in this setting.-
dc.rightsinfo:eu-repo/semantics/openAccess-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.sourceAnnals of Noninvasive Electrocardiology-
dc.titleSuccessful use of sirolimus for refractory atrial ectopic tachycardia in a child with cardiac rhabdomyoma-
dc.typearticle-
dc.identifier.doi10.1111/anec.12435-
dc.identifier.scopus2-s2.0-85013361062-
Appears in Collections:Faculty of Medical Sciences, Kragujevac

Page views(s)

491

Downloads(s)

57

Files in This Item:
File Description SizeFormat 
10.1111-anec.12435.pdf865.09 kBAdobe PDFThumbnail
View/Open
Show simple item record


This item is licensed under a Creative Commons License Creative Commons